These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20517467)

  • 1. Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis.
    McLean S; Sheikh A
    Patient Prefer Adherence; 2010 May; 4():69-76. PubMed ID: 20517467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis.
    Abelson M; Protzko E; Shapiro A; Garces-Soldana A; Bowman L
    Clin Ophthalmol; 2007 Jun; 1(2):177-82. PubMed ID: 19668507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
    Protzko E; Bowman L; Abelson M; Shapiro A;
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.
    Friedlaender MH; Protzko E
    Clin Ophthalmol; 2007 Mar; 1(1):3-10. PubMed ID: 19668461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
    Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
    Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics versus placebo for acute bacterial conjunctivitis.
    Chen YY; Liu SH; Nurmatov U; van Schayck OC; Kuo IC
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD001211. PubMed ID: 36912752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics versus placebo for acute bacterial conjunctivitis.
    Sheikh A; Hurwitz B; van Schayck CP; McLean S; Nurmatov U
    Cochrane Database Syst Rev; 2012 Sep; (9):CD001211. PubMed ID: 22972049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections.
    Opitz DL; Harthan JS
    Ophthalmol Eye Dis; 2012; 4():1-14. PubMed ID: 23650453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin in DuraSite for the treatment of blepharitis.
    Luchs J
    Clin Ophthalmol; 2010 Jul; 4():681-8. PubMed ID: 20689782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite) solution in the treatment of ocular infections.
    Utine CA
    Clin Ophthalmol; 2011; 5():801-9. PubMed ID: 21750614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
    Southern KW; Solis-Moya A; Kurz D; Smith S
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics for acute bacterial conjunctivitis.
    Sheikh A; Hurwitz B; Cave J
    Cochrane Database Syst Rev; 2000; (2):CD001211. PubMed ID: 10796757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular pharmacokinetics of AzaSite Xtra-2% azithromycin formulated in a DuraSite delivery system.
    Si EC; Cheung PS; Bowman L; Hosseini K
    Curr Eye Res; 2009 Jun; 34(6):485-91. PubMed ID: 19899983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for trachoma.
    Evans JR; Solomon AW; Kumar R; Perez Á; Singh BP; Srivastava RM; Harding-Esch E
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001860. PubMed ID: 31554017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a topical polymeric mucoadhesive ocular delivery system for azithromycin.
    Bowman LM; Si E; Pang J; Archibald R; Friedlaender M
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):133-9. PubMed ID: 19284320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
    Cluver C; Novikova N; Eriksson DO; Bengtsson K; Lingman GK
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010485. PubMed ID: 28937705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics for the treatment of COVID-19.
    Popp M; Stegemann M; Riemer M; Metzendorf MI; Romero CS; Mikolajewska A; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015025. PubMed ID: 34679203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of effectiveness and tolerance of treatment with azithromycin 1.5% eye drops in bacterial conjunctivitis].
    Ambroziak AM; Szaflik JP; Hapunik A
    Klin Oczna; 2009; 111(1-3):46-9. PubMed ID: 19517846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.